化学资讯学市场- 按产品类型（软体、服务）、应用（化学分析[化学计量学、分子建模]、虚拟筛选、药物发现和验证）、最终用途（CRO、製药、生物技术公司） - 全球预测（2024 年- 2032 年） ）

由于製药业对先进药物发现和开发流程的需求不断增长，化学资讯学市场规模从 2024 年到 2032 年可能会实现 15.5% 的复合年增长率。化学资料与资讯技术的整合使得复杂化学资讯的高效分析和视觉化成为可能，这对于识别潜在候选药物和优化先导化合物至关重要。例如，2024 年 1 月，德勤推出了 Atlas AI，这是其 Quartz AI™ 套件的突破性补充，代表了生命科学和医疗保健领域的重大进步。

在环境科学中，化学资讯学用于研究化学品对生态系统和人类健康的影响，有助于开发更安全的化学品和遵守法规。在材料科学中，它有助于设计和发现具有所需特性的新材料。计算化学的不断进步和化学资料的不断增加也将支持市场的成长。

整个产业分为产品类型、应用、最终用途和地区。

根据产品类型，服务领域的化学资讯学市场规模预计将在 2024 年至 2032 年间产生可观的收入，因为它为各行业的实施和优化提供了重要的支援和专业知识。化学资讯学服务包括咨询、客製化软体开发、培训和资料分析，可帮助组织有效地融入其工作流程，从而最大限度地提高化学资料的效用和效率。

在应用方面，化学资讯学产业将在 2032 年之前实现显着的成长。虚拟筛选显着减少了与传统实验室筛选方法相关的时间和成本，使研究人员能够快速且准确地预测化合物的生物活性。

由于中国、印度和日本製药和生物技术产业的快速扩张，到 2032 年，亚太地区化学资讯学市场规模将以复合年增长率大幅成长。这些国家越来越多地投资于药物发现和开发，以简化流程并提高研究效率。政府支持科学研究、创新和数位转型的措施将进一步推动区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 增加製药和生技产业的研发活动
    • 对个人化医疗和精准医疗保健的需求不断增长
    • 计算技术的进步
  • 产业陷阱与挑战
    • 数据品质和可用性
    • 演算法偏差和可解释性
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032

• 主要趋势
• 软体
• 服务

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 化学分析
  • 化学资料库
  • 化学计量学
  • 分子建模
  • 其他化学分析类型
• 药物发现与验证
• 虚拟筛选
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 製药和生物技术公司
• 学术及研究机构
• 合约研究组织 (CRO)
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• ACD/Labs, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• BioSolveIT GmbH
• Cadence Molecular Sciences LLC
• Centara
• ChemAxon Ltd
• Chemical Computing Group ULC
• Collaborative Drug Discovery Inc.
• Dassault Systemes
• Jubilant Biosys Ltd
• Molecular Discovery Ltd
• OpenEye Scientific Software, Inc.
• PerkinElmer Inc.
• Schrodinger, Inc.
• Scilligence

Chemoinformatics market size is likely to register a 15.5% CAGR from 2024-2032 driven by the increasing demand for advanced drug discovery and development processes in the pharmaceutical industry. The integration of chemical data with information technology is enabling the efficient analysis and visualization of complex chemical information, which is crucial for identifying potential drug candidates and optimizing lead compounds. For instance, in January 2024, Deloitte introduced Atlas AI, a groundbreaking addition to its Quartz AI(TM) suite, representing a significant advancement in the fields of life sciences and healthcare.

In environmental science, chemoinformatics is used to study the impact of chemicals on ecosystems and human health, aiding in the development of safer chemicals and regulatory compliance. In materials science, it helps in the design and discovery of new materials with desired properties. The continuous advancements in computational chemistry and the growing availability of chemical data will also support the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the chemoinformatics market size from the services segment is poised to generate substantial revenue between 2024 and 2032 owing to its essential support and expertise for the implementation and optimization across various industries. Chemoinformatics services, which include consulting, custom software development, training, and data analysis, help organizations effectively integrate into their workflows for maximizing the utility and efficiency of their chemical data.

In terms of application, the chemoinformatics industry will record a significant growth rate through 2032. This is backed by the need for revolutionizing the drug discovery process through computational methods that efficiently identify potential drug candidates from vast chemical libraries. Virtual screening significantly reduces the time and cost associated with traditional laboratory-based screening methods, enabling researchers to quickly and accurately predict the biological activity of compounds.

Asia Pacific chemoinformatics market size will grow at substantial CAGR through 2032 attributed to the rapid expansion of the pharmaceutical and biotechnology sectors in China, India, and Japan. These countries are increasingly investing in drug discovery and development for leveraging to streamline processes and enhance research efficiency. Government initiatives for supporting scientific research, innovation, and digital transformation will further fuel the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing R&D activities in pharmaceutical and biotechnology industries
    • 3.2.1.2 Rising demand for personalized medicine and precision healthcare
    • 3.2.1.3 Advancements in computational technologies
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Data quality and availability
    • 3.2.2.2 Algorithmic bias and interpretability
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Software
• 5.3 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Chemical analysis
  • 6.2.1 Chemical databases
  • 6.2.2 Chemometrics
  • 6.2.3 Molecular modelling
  • 6.2.4 Other chemical analysis types
• 6.3 Drug discovery and validation
• 6.4 Virtual screening
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical and biotechnology companies
• 7.3 Academic and research institutes
• 7.4 Contract research organizations (CROs)
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ACD/Labs, Inc.
• 9.2 Agilent Technologies, Inc.
• 9.3 Bio-Rad Laboratories, Inc.
• 9.4 BioSolveIT GmbH
• 9.5 Cadence Molecular Sciences LLC
• 9.6 Centara
• 9.7 ChemAxon Ltd
• 9.8 Chemical Computing Group ULC
• 9.9 Collaborative Drug Discovery Inc.
• 9.10 Dassault Systemes
• 9.11 Jubilant Biosys Ltd
• 9.12 Molecular Discovery Ltd
• 9.13 OpenEye Scientific Software, Inc.
• 9.14 PerkinElmer Inc.
• 9.15 Schrodinger, Inc.
• 9.16 Scilligence